Evidence map›Paper›PMID 25708447›Full record

ArticleJournal of neurochemistry2015

Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitro.

Bjørnar Hassel, Ahmed Elsais, Anne-Sofie Frøland, Erik Taubøll, Leif Gjerstad, Yi Quan, Raymond Dingledine, Frode Rise

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Effect of Increased IL-1β on Expression of HK in Alzheimer's Disease.International journal of molecular sciences · 2021
    Article
  12. The Aging GABAergic System and Its Nutritional Support.Journal of nutrition and metabolism · 2021
    Review
  13. Review
  14. Article
  15. Glucose transporters in brain in health and disease.Pflugers Archiv : European journal of physiology · 2020
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Bjørnar HasselDepartment of Neurology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Norwegian Defence Research Establishment, Kjeller, Norway.
Ahmed Elsais
Anne-Sofie Frøland
Erik Taubøll
Leif Gjerstad
Yi Quan
Raymond Dingledine
Frode Rise
Oslo University Hospital · NOEmory University · USUniversity of Oslo · NO

Funding

Prostanoid modulators that reduce brain injury and inflammation after seizuresU01NS058158 · NINDS · EMORY UNIVERSITY · PI DINGLEDINE, RAYMOND J · 2006 to 2015
$5.9M
GENETIC CONTROL OF GLUTAMATE RECEPTOR FUNCTIONR01NS036604 · NINDS · EMORY UNIVERSITY · PI DINGLEDINE, RAYMOND J · 1998 to 2008
$3.0M
MICROARRAY SCANNING SYSTEMS10RR015960 · NCRR · EMORY UNIVERSITY · PI DINGLEDINE, RAYMOND J · 2001 to 2001
$120k
NINDS NIH HHS R01 NS036604NINDS NIH HHS U01 NS058158
6 · The paper itself

Abstract

Fructose reacts spontaneously with proteins in the brain to form advanced glycation end products (AGE) that may elicit neuroinflammation and cause brain pathology, including Alzheimer's disease. We investigated whether fructose is eliminated by oxidative metabolism in neocortex. Injection of [(14) C]fructose or its AGE-prone metabolite [(14) C]glyceraldehyde into rat neocortex in vivo led to formation of (14) C-labeled alanine, glutamate, aspartate, GABA, and glutamine. In isolated neocortical nerve terminals, [(14) C]fructose-labeled glutamate, GABA, and aspartate, indicating uptake of fructose into nerve terminals and oxidative fructose metabolism in these structures. This was supported by high expression of hexokinase 1, which channels fructose into glycolysis, and whose activity was similar with fructose or glucose as substrates. By contrast, the fructose-specific ketohexokinase was weakly expressed. The fructose transporter Glut5 was expressed at only 4% of the level of neuronal glucose transporter Glut3, suggesting transport across plasma membranes of brain cells as the limiting factor in removal of extracellular fructose. The genes encoding aldose reductase and sorbitol dehydrogenase, enzymes of the polyol pathway that forms glucose from fructose, were expressed in rat neocortex. These results point to fructose being transported into neocortical cells, including nerve terminals, and that it is metabolized and thereby detoxified primarily through hexokinase activity. We asked how the brain handles fructose, which may react spontaneously with proteins to form 'advanced glycation end products' and trigger inflammation. Neocortical cells took up and metabolized extracellular fructose oxidatively in vivo, and isolated nerve terminals did so in vitro. The low expression of fructose transporter Glut5 limited uptake of extracellular fructose. Hexokinase was a main pathway for fructose metabolism, but ketohexokinase (which leads to glyceraldehyde formation) was expressed too. Neocortical cells also took up and metabolized glyceraldehyde oxidatively.

Indexed as

Amino AcidsAmino Acid Transport System X-AGAnimalsCarbon IsotopesFructokinasesFructoseFructose-Bisphosphate AldolaseGene Expression RegulationGlucoseGlyceraldehydeHexokinaseIn Vitro TechniquesMagnetic Resonance SpectroscopyMaleMetabolic Networks and PathwaysNeocortexAmino AcidsAmino Acid Transport System X-AGCarbon IsotopesFructokinasesFructoseFructose-Bisphosphate AldolaseGlucoseGlyceraldehydeHexokinaseketohexokinaseAlzheimer's diseasebrain metabolismfructoseGlut5glyceraldehydeketohexokinase

Identifiers

PMID25708447
PMCPMC4427911
OpenAlexW2143202406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.